Medicare Enrolled

Dr. Chukwuemeka Chima, MD

Infectious Disease · Fayetteville, NC
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
1774 METROMEDICAL DR, Fayetteville, NC 28304
9105683903
Registered in NPPES since 2005
NPI: 1962494377 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chima from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chima? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chima

Dr. Chukwuemeka Chima is an infectious disease specialist in Fayetteville, NC, with 21 years of NPI registration. Based on federal Medicare data, Dr. Chima performed 20,627 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Chima received a total of $27,805 from 38 pharmaceutical and/or device companies across 911 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chima is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration ▲ Top 1% volume in NC $27,805 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
20,627
Medicare services
Top 1% in NC for infectious disease
Not available
Unique patients (not deduplicated)
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dalbavancin injection, 5 mg
An injection of the antibiotic dalbavancin, administered in a 5 mg dose.
6,300 $12 $36
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 4,074 $1 $10
Injection, heparin sodium, (heparin lock flush), per 10 units 2,653 $0 $2
Injection, cefepime hydrochloride, 500 mg 2,604 $1 $10
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
1,156 $90 $175
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
856 $92 $200
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
832 $59 $125
Normal saline infusion, 1000 cc
Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution.
570 $2 $12
Refilling and maintenance of portable pump
This service involves refilling and performing maintenance on a portable pump.
556 $92 $400
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
384 $131 $325
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
235 $47 $250
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
169 $98 $270
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
67 $118 $250
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
54 $17 $80
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
51 $24 $100
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
39 $130 $270
D5W intravenous infusion, 1000 cc
Administration of 1000 cc of 5% dextrose in water through a vein.
27 $3 $40
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
4.0% high complexity
75.8% medium
20.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$27,805
Total received (2018-2024)
Avg $3,972/year across 7 years
Top 9% in NC for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
911
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,242
2023
$2,834
2022
$3,096
2021
$2,510
2020
$1,824
2019
$1,600
2018
$12,699

Payments by company (2024)

ViiV Healthcare Company
$802
Gilead Sciences, Inc.
$522
Shionogi Inc
$324
Melinta Therapeutics, LLC
$315
Paratek Pharmaceuticals, Inc.
$277
ABBVIE INC.
$256
Merck Sharp & Dohme LLC
$223
Astellas Pharma US Inc
$169
GENZYME CORPORATION
$158
Insmed, Inc.
$148
Napo Pharmaceuticals Inc
$30
Ferring Pharmaceuticals Inc.
$17
Top 3 companies account for 50.8% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan Inc.
$11,736
ViiV Healthcare Company
$4,268
Gilead Sciences, Inc.
$1,959
Paratek Pharmaceuticals, Inc.
$1,096
Shionogi Inc
$961
Melinta Therapeutics, LLC
$947
Merck Sharp & Dohme Corporation
$893
Insmed, Inc.
$635
Cumberland Pharmaceuticals, Inc.
$573
Merck Sharp & Dohme LLC
$544
ABBVIE INC.
$510
Astellas Pharma US Inc
$434
AbbVie Inc.
$412
Melinta Therapeutics, Inc.
$354
TETRAPHASE PHARMACEUTICALS, INC.
$333
Janssen Biotech, Inc.
$307
Theratechnologies Inc.
$272
Allergan, Inc.
$257
La Jolla Pharmaceutical Company
$230
Janssen Products, LP
$224
GlaxoSmithKline, LLC.
$170
GENZYME CORPORATION
$158
COMSORT, Inc
$100
Napo Pharmaceuticals Inc
$57
Takeda Pharmaceuticals U.S.A., Inc.
$46
MAYNE PHARMA INC.
$37
Pharmacosmos Therapeutics Inc.
$36
Ferring Pharmaceuticals Inc.
$36
Vyera Pharmaceuticals, LLC
$35
VYERA PHARMACEUTICALS, LLC
$32
PFIZER INC.
$27
Grifols USA, LLC
$23
AbbVie, Inc.
$23
Octapharma USA, Inc.
$22
Mycovia Pharmaceuticals, Inc.
$19
Janssen Pharmaceuticals, Inc
$17
INSYS Therapeutics Inc
$12
Nabriva Therapeutics, plc
$11
Top 3 companies account for 64.6% of all-time payments
Associated products mentioned in payments ›
APRETUDE · AVYCAZ · Arikayce · Baxdela · Biktarvy · CABENUVA · CRESEMBA · Cresemba · DALVANCE · DELSTRIGO · DIFICID · DOVATO · Daraprim · Daraprim Tablet 25mg · Descovy · EGRIFTA · ELIQUIS · Fetroja · GATTEX · GIAPREZA · ISENTRESS · JULUCA · Kimyrsa · MAVYRET · MONOFERRIC · Mavyret · Mytesi · NUZYRA · Orbactiv · PANZYGA · PIFELTRO · PREZCOBIX · REBYOTA · RUKOBIA · Rezzayo · SIVEXTRO · SYMTUZA · SYNDROS · TEFLARO · TIVICAY · TRIUMEQ · TROGARZO · VIBATIV · Vabomere · Vibativ · Vivjoa · XARELTO · XERAVA · Xembify · Xenleta · Xerava · ZERBAXA · ZINPLAVA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an infectious disease specialist in Fayetteville?
Compare infectious diseases in the Fayetteville area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious diseases in nearby ZIP areas
7
County median income
$58,780
Nearest hospital to ZIP centroid (approximate)
FAYETTEVILLE NC VA MEDICAL CENTER
6.9 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chima is a mixed practice specialist, with above-average Medicare volume (top 1% in NC), with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chima experienced with dalbavancin injection, 5 mg?
Based on Medicare claims data, Dr. Chima performed 6,300 dalbavancin injection, 5 mg services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Chima receive payments from pharmaceutical companies?
Yes. Dr. Chima received a total of $27,805 from 38 companies across 911 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chima's costs compare to other infectious diseases in Fayetteville?
Dr. Chima's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chima) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →